Preclinical or subclinical rheumatoid arthritis-associated interstitial lung disease: misleading terms with potentially deleterious consequences
- 6 February 2023
- journal article
- editorial
- Published by Elsevier in The Lancet Rheumatology
- Vol. 5 (3) , e116-e118
Abstract
No abstract availableFunding Information
- National Heart, Lung, and Blood Institute
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
This publication has 11 references indexed in Scilit:
- Prevalence and mortality associations of interstitial lung abnormalities in rheumatoid arthritis within a multicentre prospective cohort of smokersRheumatology, 2023
- Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice GuidelineAmerican Journal of Respiratory and Critical Care Medicine, 2022
- The impact of disease severity measures on survival in U.S. veterans with rheumatoid arthritis-associated interstitial lung diseaseRheumatology, 2022
- Rheumatoid Arthritis and Associated Interstitial Lung Disease: Mortality Rates and TrendsAnnals of the American Thoracic Society, 2021
- Current issues in rheumatoid arthritis-associated interstitial lung diseaseThe Lancet Rheumatology, 2021
- Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner SocietyThe Lancet Respiratory Medicine, 2020
- Rheumatoid Arthritis Disease Activity Predicting Incident Clinically Apparent Rheumatoid Arthritis–Associated Interstitial Lung Disease: A Prospective Cohort StudyArthritis & Rheumatology, 2019
- MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung DiseaseNew England Journal of Medicine, 2018
- A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortalityAnnals of the Rheumatic Diseases, 2017
- Rheumatoid Arthritis–Interstitial Lung Disease–associated MortalityAmerican Journal of Respiratory and Critical Care Medicine, 2011